Institutional investors purchased a net $716.2 thousand shares of SRPT during the quarter ended December 2013, and now own 72.86% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
COLUMBIA WANGER ASSET MANAGEMENT... Bought 1.2 Million shares of Sarepta Therapeutics Inc